EDGAR Filing Documents for 0000950170-23-039920

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0000950170-23-039920

Filing Date

2023-08-08

Accepted

2023-08-08 16:46:56

Documents

Period of Report

2023-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	avir-20230630.htm iXBRL	10-Q	2888459
2	EX-10.1	avir-ex10_1.htm	EX-10.1	51285
3	EX-10.2	avir-ex10_2.htm	EX-10.2	66193
4	EX-10.3	avir-ex10_3.htm	EX-10.3	69873
5	EX-31.1	avir-ex31_1.htm	EX-31.1	18120
6	EX-31.2	avir-ex31_2.htm	EX-31.2	18400
7	EX-32.1	avir-ex32_1.htm	EX-32.1	12804
8	EX-32.2	avir-ex32_2.htm	EX-32.2	11979
9	GRAPHIC	img145801671_0.jpg	GRAPHIC	3729
10	GRAPHIC	img145801671_1.jpg	GRAPHIC	3972
11	GRAPHIC	img145801671_2.jpg	GRAPHIC	1489
12	GRAPHIC	img145801671_3.jpg	GRAPHIC	1436
13	GRAPHIC	img145801671_4.jpg	GRAPHIC	1528
14	GRAPHIC	img145801671_5.jpg	GRAPHIC	4182
15	GRAPHIC	img145801671_6.jpg	GRAPHIC	1444
16	GRAPHIC	img145801671_7.jpg	GRAPHIC	1489
17	GRAPHIC	img145801671_8.jpg	GRAPHIC	4221
	Complete submission text file	0000950170-23-039920.txt		8945143

Data Files

Seq	Description	Document	Type	Size
18	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	avir-20230630_lab.xml	EX-101.LAB	384113
19	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	avir-20230630_def.xml	EX-101.DEF	142828
20	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	avir-20230630_pre.xml	EX-101.PRE	278716
21	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	avir-20230630.xsd	EX-101.SCH	41535
22	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	avir-20230630_cal.xml	EX-101.CAL	41118
71	EXTRACTED XBRL INSTANCE DOCUMENT	avir-20230630_htm.xml	XML	1577999

Mailing Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110

Business Address 225 FRANKLIN STREET SUITE 2100 BOSTON MA 02110 857-204-8109

Atea Pharmaceuticals, Inc. (Filer) CIK: 0001593899 (see all company filings)